Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy

Targeted alpha therapy (TAT) has garnered significant interest as an innovative cancer therapy. Owing to their high energy and short range, achieving selective α-particle accumulation in target tumor cells is crucial for obtaining high potency without adverse effects. To meet this demand, we fabrica...

Full description

Bibliographic Details
Main Authors: Yuki Iizuka, Yoshiyuki Manabe, Kazuhiro Ooe, Atsushi Toyoshima, Xiaojie Yin, Hiromitsu Haba, Kazuya Kabayama, Koichi Fukase
Format: Article
Language:English
Published: MDPI AG 2023-05-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/11/9593
_version_ 1797597311492161536
author Yuki Iizuka
Yoshiyuki Manabe
Kazuhiro Ooe
Atsushi Toyoshima
Xiaojie Yin
Hiromitsu Haba
Kazuya Kabayama
Koichi Fukase
author_facet Yuki Iizuka
Yoshiyuki Manabe
Kazuhiro Ooe
Atsushi Toyoshima
Xiaojie Yin
Hiromitsu Haba
Kazuya Kabayama
Koichi Fukase
author_sort Yuki Iizuka
collection DOAJ
description Targeted alpha therapy (TAT) has garnered significant interest as an innovative cancer therapy. Owing to their high energy and short range, achieving selective α-particle accumulation in target tumor cells is crucial for obtaining high potency without adverse effects. To meet this demand, we fabricated an innovative radiolabeled antibody, specifically designed to selectively deliver <sup>211</sup>At (α-particle emitter) to the nuclei of cancer cells. The developed <sup>211</sup>At-labeled antibody exhibited a superior effect compared to its conventional counterparts. This study paves the way for organelle-selective drug delivery.
first_indexed 2024-03-11T03:04:40Z
format Article
id doaj.art-6cdaf234eee84cfab366971b453b6f0a
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T03:04:40Z
publishDate 2023-05-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-6cdaf234eee84cfab366971b453b6f0a2023-11-18T08:01:16ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-05-012411959310.3390/ijms24119593Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha TherapyYuki Iizuka0Yoshiyuki Manabe1Kazuhiro Ooe2Atsushi Toyoshima3Xiaojie Yin4Hiromitsu Haba5Kazuya Kabayama6Koichi Fukase7Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, JapanDepartment of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, JapanRadioisotope Research Center, Institute for Radiation Sciences, Osaka University, 2-4 Yamadaoka, Suita 565-0871, Osaka, JapanDivision of Science, Institute for Radiation Sciences, Osaka University, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, JapanRIKEN Nishina Center for Accelerator-Based Science, 2-1 Hirosawa, Wako 351-0198, Saitama, JapanRIKEN Nishina Center for Accelerator-Based Science, 2-1 Hirosawa, Wako 351-0198, Saitama, JapanDepartment of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, JapanDepartment of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka 560-0043, Osaka, JapanTargeted alpha therapy (TAT) has garnered significant interest as an innovative cancer therapy. Owing to their high energy and short range, achieving selective α-particle accumulation in target tumor cells is crucial for obtaining high potency without adverse effects. To meet this demand, we fabricated an innovative radiolabeled antibody, specifically designed to selectively deliver <sup>211</sup>At (α-particle emitter) to the nuclei of cancer cells. The developed <sup>211</sup>At-labeled antibody exhibited a superior effect compared to its conventional counterparts. This study paves the way for organelle-selective drug delivery.https://www.mdpi.com/1422-0067/24/11/9593targeted alpha therapy (TAT)drug delivery system (DDS)radiolabeled antibodyα-rayimagingnuclear localization signal (NLS)
spellingShingle Yuki Iizuka
Yoshiyuki Manabe
Kazuhiro Ooe
Atsushi Toyoshima
Xiaojie Yin
Hiromitsu Haba
Kazuya Kabayama
Koichi Fukase
Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy
International Journal of Molecular Sciences
targeted alpha therapy (TAT)
drug delivery system (DDS)
radiolabeled antibody
α-ray
imaging
nuclear localization signal (NLS)
title Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy
title_full Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy
title_fullStr Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy
title_full_unstemmed Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy
title_short Exploring a Nuclear-Selective Radioisotope Delivery System for Efficient Targeted Alpha Therapy
title_sort exploring a nuclear selective radioisotope delivery system for efficient targeted alpha therapy
topic targeted alpha therapy (TAT)
drug delivery system (DDS)
radiolabeled antibody
α-ray
imaging
nuclear localization signal (NLS)
url https://www.mdpi.com/1422-0067/24/11/9593
work_keys_str_mv AT yukiiizuka exploringanuclearselectiveradioisotopedeliverysystemforefficienttargetedalphatherapy
AT yoshiyukimanabe exploringanuclearselectiveradioisotopedeliverysystemforefficienttargetedalphatherapy
AT kazuhiroooe exploringanuclearselectiveradioisotopedeliverysystemforefficienttargetedalphatherapy
AT atsushitoyoshima exploringanuclearselectiveradioisotopedeliverysystemforefficienttargetedalphatherapy
AT xiaojieyin exploringanuclearselectiveradioisotopedeliverysystemforefficienttargetedalphatherapy
AT hiromitsuhaba exploringanuclearselectiveradioisotopedeliverysystemforefficienttargetedalphatherapy
AT kazuyakabayama exploringanuclearselectiveradioisotopedeliverysystemforefficienttargetedalphatherapy
AT koichifukase exploringanuclearselectiveradioisotopedeliverysystemforefficienttargetedalphatherapy